A‐Bin You
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Extracellular vesicles in disease
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Interference and Gene Delivery
Papers in
-
- Cancer-related gene regulation 3
- RNA modifications and cancer 3
- Metabolism, Diabetes, and Cancer 2
- RNA Research and Splicing 2
- Extracellular vesicles in disease 2
- Ubiquitin and proteasome pathways 1
-
- Cancer, Hypoxia, and Metabolism 3
- Cancer-related molecular mechanisms research 3
- Co-authors
- Bingfeng Zuo (5 shared papers)HaiFang Yin (5 shared papers)Xianjun Gao (4 shared papers)Zhen Lu (3 shared papers)Quan Rao (3 shared papers)Du Zhi (2 shared papers)Chenxuan Wu (2 shared papers)Dajun Deng (4 shared papers)
In The Last Decade
A‐Bin You
17 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 74
- Cancer Research 392
- Molecular Biology 746
- Immunology 199
- Nephrology 44
- Hepatology 43
Countries citing papers authored by A‐Bin You
This map shows the geographic impact of A‐Bin You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A‐Bin You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A‐Bin You more than expected).
Fields of papers citing papers by A‐Bin You
This network shows the impact of papers produced by A‐Bin You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A‐Bin You. The network helps show where A‐Bin You may publish in the future.
Co-authors
The 25 scholars most cited alongside A‐Bin You, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 239 | |
| 2 | 2018 | 179 | |
| 3 | 2020 | 143 | |
| 4 | 2022 | 131 | |
| 5 | 2016 | 59 | |
| 6 | 2020 | 48 | |
| 7 | 2023 | 35 | |
| 8 | 2020 | 33 | |
| 9 | 2016 | 32 | |
| 10 | 2015 | 25 | |
| 11 | 2020 | 22 | |
| 12 | 2022 | 19 | |
| 13 | 2018 | 16 | |
| 14 | 2023 | 15 | |
| 15 | 2016 | 10 | |
| 16 | 2023 | 8 | |
| 17 | 2017 | 1 |
About A‐Bin You
A‐Bin You is a scholar working on Molecular Biology, Cancer Research, Immunology, Oncology and Surgery, having authored 17 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer-related gene regulation (3 papers), RNA modifications and cancer (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer-related molecular mechanisms research (3 papers), Metabolism, Diabetes, and Cancer (2 papers), RNA Research and Splicing (2 papers), Extracellular vesicles in disease (2 papers) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Cancer Research (392 citations), Molecular Biology (746 citations), Immunology (199 citations), Nephrology (44 citations) and Hepatology (43 citations). A‐Bin You has collaborated with scholars based in China, Ethiopia and Romania. Frequent co-authors include Bingfeng Zuo, HaiFang Yin, Xianjun Gao, Zhen Lu, Quan Rao, Du Zhi, Chenxuan Wu, Dajun Deng, Ti Zhang and Manqing Cao. Their work appears in journals such as Hepatology, Journal of Hematology & Oncology, Nature Communications, Advanced Science and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.